Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith Haas

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Expert Review of Neurotherapeutics|April 1, 2011
Pathophysiology, assessment and management of multiple sclerosis spasticity: an updateJudith Haas
Krankenpflege Journal|March 7, 2006
[Long-term prevention of MS: effectiveness alone is not enough]Judith Haas
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 21, 2007
A dose comparison study of IVIG in postpartum relapsing-remitting multiple sclerosisJudith Haas, Otto Roelf Hommes
Expert Review of Neurotherapeutics|April 1, 2011
Questions & answersJudith Haas, Vincenzo Di Marzo, Patrick Vermersch
Journal of the Neurological Sciences|March 27, 2007
Rituximab in chronic inflammatory demyelinating polyneuropathy associated with diabetes mellitusChristoph Münch, Pedros Anagnostou, Robert Meyer, et al.
BMC Neurology|May 26, 2023
Fatigue, depression, and product tolerability during long-term treatment with intravenous immunoglobulin (Gamunex® 10%) in patients with chronic inflammatory demyelinating polyneuropathyJuliane Klehmet, Björn Tackenberg, Judith Haas, et al.
Journal of the Neurological Sciences|December 16, 2006
Serum levels of soluble CD95 are not associated with amelioration of multiple sclerosis during pregnancyStefan Ehrlich, Judith Haas, Frauke Zipp, et al.
Journal of Neurology|March 10, 2009
IVIG trials in MS. Is albumin a placebo?Otto R Hommes, Judith Haas, Per Soelberg-Sorenson, et al.
Nature Clinical Practice. Rheumatology|August 26, 2006
Implant-related inflammatory arthritisThomas Dörner, Judith Haas, Christoph Loddenkemper, et al.
Journal of Neurology|February 16, 2006
Current issues in immunomodulatory treatment of multiple sclerosis--a practical approachMartin Stangel, Ralf Gold, Achim Gass, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Expert Review of Neurotherapeutics|April 1, 2011
Pathophysiology, assessment and management of multiple sclerosis spasticity: an updateJudith Haas
Krankenpflege Journal|March 7, 2006
[Long-term prevention of MS: effectiveness alone is not enough]Judith Haas
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 21, 2007
A dose comparison study of IVIG in postpartum relapsing-remitting multiple sclerosisJudith Haas, Otto Roelf Hommes
Expert Review of Neurotherapeutics|April 1, 2011
Questions & answersJudith Haas, Vincenzo Di Marzo, Patrick Vermersch
Journal of the Neurological Sciences|March 27, 2007
Rituximab in chronic inflammatory demyelinating polyneuropathy associated with diabetes mellitusChristoph Münch, Pedros Anagnostou, Robert Meyer, et al.
BMC Neurology|May 26, 2023
Fatigue, depression, and product tolerability during long-term treatment with intravenous immunoglobulin (Gamunex® 10%) in patients with chronic inflammatory demyelinating polyneuropathyJuliane Klehmet, Björn Tackenberg, Judith Haas, et al.
Journal of the Neurological Sciences|December 16, 2006
Serum levels of soluble CD95 are not associated with amelioration of multiple sclerosis during pregnancyStefan Ehrlich, Judith Haas, Frauke Zipp, et al.
Journal of Neurology|March 10, 2009
IVIG trials in MS. Is albumin a placebo?Otto R Hommes, Judith Haas, Per Soelberg-Sorenson, et al.
Nature Clinical Practice. Rheumatology|August 26, 2006
Implant-related inflammatory arthritisThomas Dörner, Judith Haas, Christoph Loddenkemper, et al.
Journal of Neurology|February 16, 2006
Current issues in immunomodulatory treatment of multiple sclerosis--a practical approachMartin Stangel, Ralf Gold, Achim Gass, et al.
Pageof 5